No Data
No Data
Relief Therapeutics to Get European Patent for Investigational Drug RLF‐TD011
Relief Therapeutics Completes Strategic Transition With Sale of GOLIKE Rights Ex-US
Relief Therapeutics Provides Update on Potential Transaction With Renexxion
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment